Vitamin D3 from sunlight may improve the prognosis of breast-, colon- and prostate cancer (Norway)

Cancer Causes and Control

Volumn 15, Issue 2, 2004, Pages 149-158

  Robsahm, Trude Eid ^a   Tretli, Steinar ^a,b   Dahlback, Arne ^c   Moan, Johan ^c,d  

^a CANCER REGISTRY OF NORWAY   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d INSTITUTE OF CANCER RESEARCH   (Norway)

Author keywords

Breast; Colon and prostate cancer; Prognosis; Sunlight; Vitamin D

Indexed keywords

COLECALCIFEROL;

ADULT; AGED; ARTICLE; AUTUMN; BREAST CANCER; CANCER MORTALITY; CANCER RISK; CLIMATE; COLON CANCER; EDUCATION; FEMALE; GEOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; NORWAY; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; SEASONAL VARIATION; SUMMER; SUN EXPOSURE; SUNLIGHT; ULTRAVIOLET RADIATION; BIOSYNTHESIS; BREAST TUMOR; COLON TUMOR; EDUCATIONAL STATUS; MORTALITY; OCCUPATIONAL EXPOSURE; PHYSIOLOGY; PROSTATE TUMOR; RISK FACTOR; SEASON; TREATMENT OUTCOME;

BREAST NEOPLASMS; CHOLECALCIFEROL; COLONIC NEOPLASMS; EDUCATIONAL STATUS; FEMALE; HUMANS; MALE; NORWAY; OCCUPATIONAL EXPOSURE; PROGNOSIS; PROSTATIC NEOPLASMS; RISK FACTORS; SEASONS; SUNLIGHT; TREATMENT OUTCOME;

EID: 1842534563     PISSN: 09575243     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:CACO.0000019494.34403.09     Document Type: Article

References (47)

1. 3. Proc Nat Acad Sci 78: 4990-4994.
2. Danielsson C (1998) Molecular Mechanism of Cell Regulatory Properties of Vitamin D Analogues in Human Cancer Cells Lines. Sweden: Acta Univercitas Upsaliensis.
3. 3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science 206: 1188-1190.
4. Mehta RG, Mehta RR (2002) Vitamin D and cancer. J Nutr Biochem 13: 252-264.
5. Buras R, Schumaker LM, Davoodi F, et al. (1994) Vitamin D receptors in breast cancer cells. Breast Cancer Res Treat 31: 191-202.
6. Cross HS, Bajna E, Bises G, et al. (1996) Vitamin D receptor and cytokeratin expression may be progression indicators in human colon cancer. Anticancer Res 16: 2333-2338.
7. El Abdaimi K, Dion N, Papavasiliou V, et al. (2000) The vitamin D analougue EB 1089 prevents skeletal metastasis and prolongs survival time in nude mice transplanted with human breast cancer cells. Cancer Res 60: 4412-4418.
8. Mantell DJ, Owens PE, Bundred NJ, et al. (2000) 1,25-dihydroxyvitamin D (3) inhibits angiogenesis in vitro and in vivo. Circ Res 87: 214-220.
9. Bareis P, Bises G, Bischof MG, Cross HS, Peterlik M (2001) 25-hydroxyvitamin D metabolism in human colon cancer cells during tumor progression. Biochem Biophys Res Comm 285: 1012-1017.
10. Lamprecht SA, Lipkin M (2001) Cellular mechanisms of calcium and vitamin D in the inhibition of colorectal carcinogenesis. Ann NY Acad Sci 952: 73-87.
11. 3 analog, EB 1089, with ionizing radiation reduces tumor growth and induces apoptosis of MCF-7 breast tumor xenografts in nude mice. Clin Cancer Res 9: 2350-2356.
12. Garland FC, Garland CF, Gorham ED, Young JF (1990) Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med 19: 614-622.
13. Gorham ED, Garland FC, Garland CF (1990) Sunlight and breast cancer incidence in the USSR. Int J Epidemiol 19: 820-824.
14. John EM, Schwarts GG, Dreon DM, Koo J (1999) Vitamin D and breast cancer risk: the NHANES I Epidemiological follow-up study, 1971-1975 to 1992. Cancer Epidemiol Biomark Prev 8: 399-406.
15. Freedman DM, Dosemeci M, McGlynn K (2002) Sunlight and mortality from breast, ovarian, colon, prostate, and non-melanoma skin cancer: a composite death certificate based case-control study. Occup Environ Med 59: 257-262.
16. Grant WB (2002) An estimate of premature cancer mortality in the US due to inadequate doses of solar ultraviolet-B radiation. Cancer 94: 1867-1875.
17. Grant WB (2002) An ecological study of dietary and solar ultraviolet-B links to breast carcinoma mortality rates. Cancer 94: 272-281.
18. Garland C, Barrett-Connor E, Rossof AH, Shekelle RB, Criqui MH, Paul O (1985) Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet 9: 307-309.
19. Martinez ME, Willett WC (1998) Calcium, vitamin D, and colorectal cancer: a review of the epidemiologic evidence. Cancer Epidemiol Biomarkers Prev 7: 163-168.
20. Schwartz GG, Hulka BS (1990) Is vitamin D defiance a risk factor for prostate cancer? (hypothesis). Anticancer Res 10: 1307-1311.
21. Schwartz GG, Wang MH, Zhang M, Singh RK, Siegal GP (1997) 1α,25-Dihydroxyvitamin D (Calcitriol) inhibits the invasiveness of human prostate cancer cell. Cancer Epidemiol Biomark Prev 6: 727-732.
22. Luscombe CL, Fryer AA, French ME, et al. (2001) Exposure to ultraviolet radiation: association with susceptibility and age at presentation with prostate cancer. Lancet 358: 641-642.
23. 3 and its photoisomers in human skin. Science 216: 1001-1003.
24. McLaughlin M, Raggat PR, Faimey A, Brown DJ, Lester E, Wills MR (1974) Seasonal variation in serum 25-hydroxycholecalciferol in healthy people. Lancet (i) 536-540.
25. Stamp TCB, Round JM (1974) Seasonal changes in human plasma levels of 25-hydroxyvitamin D. Nature 247: 563-569.
26. Lund B, Sørensen OH (1979) Measurement of 25-hydroxyvitamin D in serum and its relation to sunshine, age and vitamin-D intake in the Danish population. Scand J Clin Lab Invest 39: 23-30.
27. Poskitt EME, Cole TJ, Lawson DEM (1979) Diet, sunlight and 25-hydroxyvitamin D in healthy children and adults. Br Med J 1: 221-223.
28. Vik T, Try K, Strømme JH (1980) The vitamin D status of man at 70° north. Scand J Clin Lab Invest 40: 227-232.
29. McKenna KJ (1992) Differences in vitamin D status between countries in young adults and the elderly. Am J Med 93: 69-77.
30. Holick MF, McCollum C (1994) Award lectures. Vitamin D: new horizons for the 21st century. Am J Clin Nutr 60: 619-630.
31. Moan J, Dahlback A, Henriksen T, Magnus K (1989) Biological amplification factor for sunlight-induced nonmelanoma skin cancer at high latitudes. Cancer Res 49: 5207-5212.
32. Dahlback A (1996) Measurements of biologically effective UV doses, total ozone abundances, and cloud effects with multichannel, moderate bandwidth filter instruments. Appl Opt 35: 6514-6521.
33. International Labour Office, ILO (1962) International Standard Classification of Occupations 1958. Genova: ILO.
34. Norusis MJ (2001) SPSS for Windows, Base System User's Guide Release 11.0. Chicago, Illinois: SPSS Inc.
35. Van der Wielen RPJ, Lowik MRH, Van den Berg H, et al. (1995) Serum vitamin D concentrations among elderly people in Europe. Lancet 346: 207-210.
36. 3 and intestinal Vitamin D receptor concentrations in normal women. J Clin Endocrinol Metab 75: 176-182.
37. Johnsen B, Mikkelborg O, Hannevik M, Nilsen LT, Saxebøl G, Blaasaas KG (2002) The Norwegian UV-monitoring program, period 1995/96 to 2001. Østerås: Norwegian Radiation Protection Authority.
38. 3. Ann Rev Nutr 8: 375-399.
39. The National Council of Nutrition and Physical Activity, NCNPA (1982) Kostholdsmessig Analyse av Matvarekjøp hos Grupper av Privathusholdninger 1977-1979. Oslo: Statistics Norway.
40. Janowsky EC, Lester GE, Weinberg CR, et al. (1999) Association between low levels of 1,25-dihydroxyvitamin D and breast cancer. Pub Health Nutr 2: 283-291.
41. Gunter E, Looker A, Lavoie D, Twite D, Calvo M (1997) 25-OH-vitamin D levels in the United States population: NHANES III (1988-1994). In: Norman AW, Bouillon R, Thomasset M, eds. Vitamin D: Chemistry, Biology and Clinical Applications of the Steroid Hormone. Riverside, CA: University of California, pp. 709-710.
42. Cross HS, Kallay E, Farhan H, Weiland T, Manhardt T (2003) Regulation of extrarenal vitamin D metabolism as a tool for colon and prostate cancer prevention. Cancer Res 164: 413-425.
43. 3 receptor: a network of coactivator interactions. Gene 246: 9-21.
44. Hofer H, HO G-M, Peterlik M, et al. (1999) Biological effects of 1α-hydroxy-and 1β-(hydroxymethyl)-vitamin D compounds relevant for potential colorectal cancer therapy. J Pharma Exper Therap 291: 450-455.
45. Deluca HF, Cantora MT (2001) Vitamin D: its role and uses in immunology. FASEB J 15: 2579-2585.
46. Kravdal Ø (1999) Social inequalities in cancer survival. Tidskr Nor Lœgeforen 119: 1577-1583.
47. The National Council on Nutrition and Physical Activity, NCNPA (1989) Rapport om Vitamin D Inntak og Vitamin D Status i den Norske Befolkning. Oslo: NCNPA.